Effects of Patent Foramen Ovale in Migraine: a Metabolomics-based Study

Overview

Journal J Physiol

Date 2025 Jan 22

PMID 39838589

Authors

Bosi Dong

Xin Li

Lu Zhang

Ge Liang

Wen Zheng

Luolan Gui

Shuming Ji

Yusha Tang

Hua Li

Wanling Li

Ruiqi Yang

Yajiao Li

Anjiao Peng

Yucheng Chen

Meng Gong

Lei Chen

Affiliations

Soon will be listed here.

Abstract

Patent foramen ovale (PFO), a cardiac anatomical anomaly inducing abnormal haemodynamics, leads to a paradoxical bypass of the pulmonary circulation. PFO closure might alleviate migraines; however, clinical evidence and basic experiments for the relationship are lacking. To explore the effect of PFO on migraine, 371 migraineurs finishing blood tests and contrast transthoracic echocardiography for the detection of PFO were prospectively included. Multivariate regression analysis revealed that PFO was independently associated with aura, and lower cystatin-C (cys-C) and calcium levels. Among them, patients with PFO who underwent percutaneous PFO closure were continuously followed up 1 year after the operation. The intensity of migraine was significantly relieved and the levels of cys-C and calcium increased after PFO closure. Untargeted and targeted metabolomics of plasma from migraineurs before and after PFO closure revealed that 5-HT and glutathione (GSH) metabolites were differentially expressed after PFO closure. The differential metabolites were then validated in the plasma and brain tissues of PFO mouse models by LC-MS/MS analysis. Desorption electrospray ionization mass imaging demonstrated that these metabolic alterations occurred mainly in the posterior cerebral cortex. Collectively, aura, cys-C and calcium could be biomarkers of migraineurs with PFO. PFO might have an impact on the posterior head associated with the regulation of 5-HT and GSH. PFO closure might relieve migraine by improving 5-HT clearance metabolism and ameliorating redox reactions. Our results may provide evidence for an indication of PFO closure in migraine and support the related potential mechanism. KEY POINTS: Aura, and levels of cystatin-C and calcium are biomarkers of migraineurs with a patent foramen ovale (PFO). The clearance of pulmonary metabolism of 5-HT and deoxygenated blood might be the reason for the improvement of migraine symptoms in patients with PFO. The posterior region of the brain is the main area responsible for PFO-induced migraine.

References

Yin P, Anttila V, Siewert K, Palotie A, Davey Smith G, Voight B . Serum calcium and risk of migraine: a Mendelian randomization study. Hum Mol Genet. 2016; 26(4):820-828. PMC: 5409060. DOI: 10.1093/hmg/ddw416. View

Dong B, Lu Y, He S, Li B, Li Y, Lai Q . Multisite and multitimepoint proteomics reveal that patent foramen ovale closure improves migraine and epilepsy by reducing right-to-left shunt-induced hypoxia. MedComm (2020). 2023; 4(4):e334. PMC: 10422075. DOI: 10.1002/mco2.334. View

Charles R, Burgoyne J, Mayr M, Weldon S, Hubner N, Dong H . Redox regulation of soluble epoxide hydrolase by 15-deoxy-delta-prostaglandin J2 controls coronary hypoxic vasodilation. Circ Res. 2010; 108(3):324-34. PMC: 3259859. DOI: 10.1161/CIRCRESAHA.110.235879. View

Mojadidi M, Ruiz J, Chertoff J, Zaman M, Elgendy I, Mahmoud A . Patent Foramen Ovale and Hypoxemia. Cardiol Rev. 2018; 27(1):34-40. DOI: 10.1097/CRD.0000000000000205. View

Reed D, Pascoe G, Thomas C . Extracellular calcium effects on cell viability and thiol homeostasis. Environ Health Perspect. 1990; 84:113-20. PMC: 1567637. DOI: 10.1289/ehp.9084113. View

Akdag T, Uca A . Cystatin C as a potential biomarker to evaluate migraine. Arq Neuropsiquiatr. 2020; 78(6):337-341. DOI: 10.1590/0004-282X20200005. View

Al Zaabi M, Ali H, Ali B . Effect of flaxseed on systemic inflammation and oxidative stress in diabetic rats with or without chronic kidney disease. PLoS One. 2021; 16(10):e0258800. PMC: 8525749. DOI: 10.1371/journal.pone.0258800. View

Nishiyama K, Konishi A, Nishio C, Araki-Yoshida K, Hatanaka H, Kojima M . Expression of cystatin C prevents oxidative stress-induced death in PC12 cells. Brain Res Bull. 2005; 67(1-2):94-9. DOI: 10.1016/j.brainresbull.2005.05.020. View

Simonsen A, McGuire J, Hansson O, Zetterberg H, Podust V, Davies H . Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment. Arch Neurol. 2007; 64(3):366-70. DOI: 10.1001/archneur.64.3.366. View

10.

Katunuma N . Mechanisms and regulation of lysosomal proteolysis. Revis Biol Celular. 1989; 20:35-61. View

11.

Kalaycioglu E, Gokdeniz T, Aykan A, Gursoy M, Gul I, Ayhan N . Evaluation of right ventricle functions and serotonin levels during headache attacks in migraine patients with aura. Int J Cardiovasc Imaging. 2014; 30(7):1255-63. DOI: 10.1007/s10554-014-0456-2. View

12.

Selli C, Tosun M . Effects of cyclopiazonic acid and dexamethasone on serotonin-induced calcium responses in vascular smooth muscle cells. J Physiol Biochem. 2016; 72(2):245-53. PMC: 4873523. DOI: 10.1007/s13105-016-0474-8. View

13.

Teepker M, Munk K, Mylius V, Haag A, Moller J, Oertel W . Serum concentrations of s100b and NSE in migraine. Headache. 2008; 49(2):245-52. DOI: 10.1111/j.1526-4610.2008.01228.x. View

14.

Kutty S, Sengupta P, Khandheria B . Patent foramen ovale: the known and the to be known. J Am Coll Cardiol. 2012; 59(19):1665-71. DOI: 10.1016/j.jacc.2011.09.085. View

15.

Harder A, Vijfhuizen L, Henneman P, Willems van Dijk K, Van Duijn C, Terwindt G . Metabolic profile changes in serum of migraine patients detected using H-NMR spectroscopy. J Headache Pain. 2021; 22(1):142. PMC: 8903680. DOI: 10.1186/s10194-021-01357-w. View

16.

Rundek T, Elkind M, Di Tullio M, Carrera E, Jin Z, Sacco R . Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation. 2008; 118(14):1419-24. PMC: 2737546. DOI: 10.1161/CIRCULATIONAHA.108.771303. View

17.

Lu L, Xia Z, Guo J, Xiao L, Zhang Y . Metabolomics analysis reveals perturbations of cerebrocortical metabolic pathways in the Pah mouse model of phenylketonuria. CNS Neurosci Ther. 2019; 26(4):486-493. PMC: 7080435. DOI: 10.1111/cns.13214. View

18.

Sanchez J, Guillaume E, Lescuyer P, Allard L, Carrette O, Scherl A . Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease. Proteomics. 2004; 4(8):2229-33. DOI: 10.1002/pmic.200300799. View

19.

Sun R, Eriksson S, Wang L . Oxidative stress induced S-glutathionylation and proteolytic degradation of mitochondrial thymidine kinase 2. J Biol Chem. 2012; 287(29):24304-12. PMC: 3397856. DOI: 10.1074/jbc.M112.381996. View

20.

Nagai A, Murakawa Y, Terashima M, Shimode K, Umegae N, Takeuchi H . Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases. Neurology. 2001; 55(12):1828-32. DOI: 10.1212/wnl.55.12.1828. View